Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
21.80
+0.79 (3.76%)
At close: Feb 6, 2026, 4:00 PM EST
21.54
-0.26 (-1.19%)
After-hours: Feb 6, 2026, 7:13 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Immune-based Therapies
5.00M
Immune-based Therapies Growth
-90.00%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
5.00M
United States Growth
-90.00%